KYTX — Kyverna Therapeutics, Inc.
Price · 2024-08-26 → 2026-08-21
499 daily closes shownAnonymous view is capped at two years of history. A free account extends it to five, and Pro opens the whole archive back to 2024-02-08.
Performance
Technicals
Others in Healthcare
Measured signals that fired on KYTX
| date | signal | measured base rate |
|---|---|---|
| 2026-07-17 | Equal lows taken out structure | -0.64% over 21 days · t = -4.75 · n = 55,661 statistically distinguishable from its control group |
| 2026-07-13 | Fair value gap, bearish structure | -0.45% over 21 days · t = -3.29 · n = 108,591 statistically distinguishable from its control group |
| 2026-07-07 | Bollinger bandwidth breaks out of its own compression structure | -0.63% over 21 days · t = -2.80 · n = 7,196 statistically distinguishable from its control group |
| 2026-04-22 | Short volume far above its own normal short | -0.76% over 21 days · t = -2.79 · n = 5,897 statistically distinguishable from its control group |
| 2026-04-20 | Breakout to a 52-week high price | -1.00% over 21 days · t = -8.58 · n = 24,386 statistically distinguishable from its control group |
Excess return against a matched control group, on a point-in-time universe that includes delisted companies. Most families do not survive that. How the measurement works →
Insider transactions (Form 4)
| date | insider | what | shares | price | value |
|---|---|---|---|---|---|
| 2026-05-27 | Shaw Christi Executive Chairperson | Shares withheld for tax | 4.2K | 8.59 | 36.0K |
| 2026-05-27 | Aktar Mert Director | Grant or award | 5.1K | 0.00 | 0 |
| 2026-05-27 | SEIDENBERG BETH C Director | Grant or award | 5.1K | 0.00 | 0 |
| 2026-05-27 | CLARK IAN T Director | Grant or award | 5.1K | 0.00 | 0 |
| 2026-05-27 | Cohen Fred E Director | Grant or award | 5.1K | 0.00 | 0 |
| 2026-03-13 | GEHCHAN NAJI See Remarks | Grant or award | 18.0K | 0.00 | 0 |
| 2026-03-13 | Biddle Warner Weston Chief Executive Officer | Grant or award | 58.0K | 0.00 | 0 |
| 2026-03-13 | GRASSO MARC Chief Financial Officer | Grant or award | 10.0K | 0.00 | 0 |
| 2026-02-24 | Emany Sravan Kumar Director | Grant or award | 11.0K | 0.00 | 0 |
| 2026-02-24 | Miller Andrew Craig Director | Grant or award | 11.0K | 0.00 | 0 |
Open-market purchases (code P) are the informative ones. Grants, option exercises and tax withholding are compensation mechanics, not decisions. How to read a Form 4 →
Largest institutional holders
| manager | value | shares |
|---|---|---|
| GordonMD Global Investments LP | 36.6M | 4.2M |
| GILEAD SCIENCES, INC. | 35.6M | 4.1M |
| Bain Capital Life Sciences Investors, LLC | 26.8M | 3.1M |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 17.3M | 2.0M |
| AIGH Capital Management LLC | 17.3M | 2.0M |
| VANGUARD CAPITAL MANAGEMENT LLC | 15.4M | 1.8M |
| Balyasny Asset Management L.P. | 9.7M | 1.1M |
| MILLENNIUM MANAGEMENT LLC | 8.7M | 1.0M |
| Insight Holdings Group, LLC | 8.5M | 989.1K |
| MORGAN STANLEY | 8.4M | 977.3K |
13F positions as of 2026-03-31, filed up to 45 days after quarter end. Long-only US equity — shorts and derivatives never appear. What 13F does and does not show →
Latest SEC filings
| form | filed | period | |
|---|---|---|---|
| SCHEDULE 13G/A | 2026-08-14 | — | on EDGAR ↗ |
| 10-Q | 2026-08-11 | 2026-06-30 | on EDGAR ↗ |
| 8-K | 2026-08-11 | 2026-08-11 | on EDGAR ↗ |
| SCHEDULE 13G | 2026-07-29 | — | on EDGAR ↗ |
| 8-K | 2026-07-27 | 2026-07-23 | on EDGAR ↗ |
| 8-K | 2026-07-09 | 2026-07-08 | on EDGAR ↗ |
| 8-K | 2026-06-02 | 2026-05-27 | on EDGAR ↗ |
| 4 | 2026-05-29 | 2026-05-27 | on EDGAR ↗ |
Short selling
This is off-exchange short volume, not short interest: it is flow, not position, and 40–50% is normal because market makers short to fill your buy. Why that number misleads →
Ask the AI about KYTX
The assistant reads every block on this page — price history, filings, insider transactions, institutional positions, short volume, macro and the measured base rates — and says what it implies, quoting the number behind each claim and declaring what it does not have.
Everything on this page is live in the terminal.
Charts, filings, insider flow and the AI — open without an account.
Free plan for good. Pro is $69.99/mo, or $4.99 for a 7-day trial. See the plans →